Stay updated on Fovista + Lucentis vs Lucentis: Safety Efficacy Clinical Trial

Sign up to get notified when there's something new on the Fovista + Lucentis vs Lucentis: Safety Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fovista + Lucentis vs Lucentis: Safety Efficacy Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:18:19.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a shift in the mean change in visual acuity (ETDRS letters) from baseline at the month 12 visit in a Phase 3 study evaluating the safety and efficacy of intravitreal administration of Fovista® in combination with Lucentis® compared to Lucentis® monotherapy for subjects with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Difference
    0.1%
    Check dated 2024-06-06T14:24:47.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study subjects, specifying age, health conditions, and prior treatments required for participation. Previously, no information was provided in this section.
    Difference
    10%
    Check dated 2024-05-22T20:28:49.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:43:07.000Z thumbnail image

Stay in the know with updates to Fovista + Lucentis vs Lucentis: Safety Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fovista + Lucentis vs Lucentis: Safety Efficacy Clinical Trial page.